According to PeptiDream 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 28.5455. At the end of 2022 the company had a P/E ratio of 35.7.
Year | P/E ratio | Change |
---|---|---|
2022 | 35.7 | -77.07% |
2021 | 156 | 5.16% |
2020 | 148 | |
2018 | 151 | -64.92% |
2017 | 430 | 113.01% |
2016 | 202 | 14.31% |
2015 | 177 | -91.82% |
2014 | > 1000 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.